Prime Medicine PRME Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$49.12M-6.6% | -$46.08M+8.9% | -$50.58M+3.8% | -$52.59M-1.4% | -$51.89M-22.7% | ||
| $1.86M-1.1% | $1.88M-0.3% | $1.88M+0.9% | $1.86M+9.6% | $1.7M-1.0% | ||
| $4.64M+2.9% | $4.52M-64.6% | $12.75M+102% | $6.33M+11.3% | $5.68M-4.4% | ||
| $0— | —— | -$120K-217% | $103K+506% | $17K— | ||
| $3.55M— | —— | $3.04M+191% | -$3.35M-278% | $1.88M— | ||
| -$4.5M— | —— | -$1.07M— | —— | -$6.66M— | ||
| -$1.22M+53.0% | -$2.6M-100% | -$1.3M+10.0% | -$1.44M-283% | $789K-87.7% | ||
| -$856K-14.0% | -$751K+36.1% | -$1.18M-18.1% | -$995K+30.8% | -$1.44M— | ||
| $0-100% | $539K-62.9% | $1.45M+388% | -$505K+52.2% | -$1.06M— | ||
| $2.84M+9.2% | $2.6M+11.5% | $2.33M-0.6% | $2.35M-2.7% | $2.41M+9.3% | ||
| -$1.92M-12.1% | -$1.71M-6.7% | -$1.6M-13.1% | -$1.42M-122% | -$638K-40.5% | ||
| -$42.71M-14.6% | -$37.26M-6.3% | -$35.04M+15.4% | -$41.41M+15.2% | -$48.86M— | ||
| $214K-26.2% | $290K+17.4% | $247K-84.3% | $1.57M-35.1% | $2.42M+35.2% | ||
| $7.28M-54.1% | $15.88M-88.2% | $134.31M+1,844% | $6.91M-85.7% | $48.32M— | ||
| $50.89M— | —— | $42.43M+277% | $11.25M+275% | $3M+102% | ||
| $43.39M— | —— | -$92.12M— | —— | -$47.74M-199% | ||
| $393K— | $0— | $0— | $0— | $0— | ||
| $393K-30.1% | $562K-99.6% | $144.75M+73,379% | $197K-96.7% | $6M+599,900% | ||
| $1.07M+113% | -$8.36M— | —— | -$38.44M+57.6% | -$90.6M-240% | ||
| $431K-45.3% | $788K+37.3% | $574K+39.7% | $411K+151% | $164K+13.1% | ||
| -$4.5M— | —— | -$1.07M— | —— | -$6.66M— | ||
| -$1.92M-12.1% | -$1.71M-6.7% | -$1.6M-13.1% | -$1.42M-122% | -$638K-40.5% | ||
| -$1.22M+53.0% | -$2.6M-100% | -$1.3M+10.0% | -$1.44M-283% | $789K-87.7% | ||
| $2.84M+9.2% | $2.6M+11.5% | $2.33M-0.6% | $2.35M-2.7% | $2.41M+9.3% | ||
| —— | $0— | $0— | $0— | $0+100% | ||
| $7.28M-54.1% | $15.88M-88.2% | $134.31M+1,844% | $6.91M-85.7% | $48.32M— | ||
| $50.89M+30.1% | $39.1M-7.9% | $42.43M+277% | $11.25M+275% | $3M-90.9% | ||
| $0— | —— | $6M— | —— | $6M— | ||
| $0-100% | $114K+177% | -$148K— | —— | $985K-5.6% | ||
| -$856K-14.0% | -$751K+36.1% | -$1.18M-18.1% | -$995K+30.8% | -$1.44M— | ||
| -$1.92M-12.1% | -$1.71M-6.7% | -$1.6M-13.1% | -$1.42M-122% | -$638K-40.5% | ||
| $0— | —— | —— | —— | $83.76M— | ||
| $0— | —— | —— | —— | $3.12M— | ||
| —— | $2.73M0.0% | $2.73M0.0% | $2.73M0.0% | $2.73M— | ||
| -$42.92M-14.3% | -$37.55M-6.4% | -$35.29M+17.9% | -$42.98M+16.2% | -$51.28M— | ||
| -$42.92M-14.3% | -$37.55M-6.4% | -$35.29M+17.9% | -$42.98M+16.2% | -$51.28M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Prime Medicine generate?
- Prime Medicine (PRME) generated -$156.4M in operating cash flow over the trailing twelve months.
- What is Prime Medicine's free cash flow?
- After $2.3M of capital expenditures, Prime Medicine's free cash flow was -$158.7M over the trailing twelve months, up 19.0% year over year.
- Where does Prime Medicine's cash flow data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
